BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11529592)

  • 1. Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease.
    Corbett M; Schlup M
    Intern Med J; 2001 Aug; 31(6):366-7. PubMed ID: 11529592
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypersensitivity reaction to azathioprine in a patient with ulcerative colitis. Infrequent manifestations.
    Mayo JM; Colmenarejo MB; Vaquerizo PJ; Gutierrez MV
    Inflamm Bowel Dis; 2004 Sep; 10(5):700. PubMed ID: 15472540
    [No Abstract]   [Full Text] [Related]  

  • 3. Sweet syndrome as a manifestation of azathioprine hypersensitivity.
    El-Azhary RA; Brunner KL; Gibson LE
    Mayo Clin Proc; 2008 Sep; 83(9):1026-30. PubMed ID: 18775203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine hypersensitivity presenting as sweet syndrome in a child with ulcerative colitis.
    Kim MJ; Jang KT; Choe YH
    Indian Pediatr; 2011 Dec; 48(12):969-71. PubMed ID: 22253154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPMT in the treatment of inflammatory bowel disease with azathioprine.
    Qasim A; Seery J; Buckley M; Morain CO
    Gut; 2003 May; 52(5):767; author reply 767-7. PubMed ID: 12692068
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe muscular weakness: an unusual adverse effect of azathioprine therapy.
    Karhadkar AS; Schwartz HJ; Arora M; Dutta SK
    J Clin Gastroenterol; 2006 Aug; 40(7):626-8. PubMed ID: 16917406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three hospital admissions in 9 days to diagnose azathioprine hypersensitivity in a patient with Crohn's disease.
    Mookherjee S; Narayanan M; Uchiyama T; Wentworth KL
    Am J Ther; 2015; 22(2):e28-32. PubMed ID: 23782763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Dec; 153(49-50):20-1. PubMed ID: 22308586
    [No Abstract]   [Full Text] [Related]  

  • 9. Not so non-specific inflammatory disease of the colon.
    Med J Aust; 1970 Jun; 1(26):1271-2. PubMed ID: 5449511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Azathioprine in chronic inflammatory bowel diseases. Evidence base].
    Herrlinger K; Stange EF
    Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine hypersensitivity reaction in a patient with ulcerative colitis.
    Garey KW; Streetman DS; Rainish MC
    Ann Pharmacother; 1998 Apr; 32(4):425-8. PubMed ID: 9562137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe life-threatening diarrhea caused by azathioprine but not by 6-mercaptopurine.
    Marbet U; Schmid I
    Digestion; 2001; 63(2):139-42. PubMed ID: 11244253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine induced colitis: a case report and review of the literature.
    Bossuyt P; Vergauwe P; Inderadjaja N; Vermeire S
    Acta Gastroenterol Belg; 2007; 70(3):302-5. PubMed ID: 18074743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity to azathioprine in a patient with Crohn's disease: a case report.
    Sousa M; Proença L; Carvalho J
    Rev Esp Enferm Dig; 2017 Oct; 109(10):735. PubMed ID: 28929775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of inflammatory bowel disease with azathioprine: how to use it in 1999.
    Louis E; Belaiche J
    Acta Gastroenterol Belg; 1999; 62(4):437-9. PubMed ID: 10692777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
    Holtmann MH; Krummenauer F; Claas C; Kremeyer K; Lorenz D; Rainer O; Vogel I; Böcker U; Böhm S; Büning C; Duchmann R; Gerken G; Herfarth H; Lügering N; Kruis W; Reinshagen M; Schmidt J; Stallmach A; Stein J; Sturm A; Galle PR; Hommes DW; D'Haens G; Rutgeerts P; Neurath MF
    Dig Dis Sci; 2010 Apr; 55(4):1066-78. PubMed ID: 19513841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neutrophilic eccrine hidradenitis and azathioprine hypersensitivity syndrome].
    Schmutz JL
    Ann Dermatol Venereol; 2014 Nov; 141(11):738-9. PubMed ID: 25442482
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rethinking in the treatment of inflammatory bowel diseases. To start aggressively right in the beginning?].
    Vetter C
    MMW Fortschr Med; 2003 Jun; 145(24):14. PubMed ID: 12866291
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
    Andrejic J; Rojas-Balcazar J; Dennis M; Berkelhammer C
    Inflamm Bowel Dis; 2010 Nov; 16(11):1828-9. PubMed ID: 20196148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.